Comparison of the extrapancreatic action of BRX-220 and pioglitazone in the high-fat diet-induced insulin resistance

Annals of the New York Academy of Sciences

Volumn 967, Issue , 2002, Pages 424-430

  Šeböková, Elena ^a   Kürthy, Maria ^b   Mogyorosi, T ^b   Nagy, Karoly ^b   Demcákova, Edita ^a   Ukropec, Jozef ^a   Koranyi, Laszlo ^b   Klimeš, Iwar ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^b POB 348 H 8201   (Hungary)

Author keywords

BRX 220; HF diet; Insulin action; Lipids; Pioglitazone

Indexed keywords

ANTIDIABETIC AGENT; BRX 220; FATTY ACID; GLUCOSE; GLYCEROL; INSULIN; PIOGLITAZONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; FAT INTAKE; FATTY ACID BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; MALE; NONHUMAN; OBESITY; RAT; SKELETAL MUSCLE;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0036291433     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04298.x     Document Type: Conference Paper

References (30)

1. Pathogenesis of NIDDM
2. Progress in population analyses of the insulin resistance syndrome
3. New drugs against insulin resistance
4. Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes
5. Multifunctional actions of vanadium compounds on insulin signaling pathways: Evidence for preferential enhancement of metabolic versus mitogenic effects
6. Molecular mechanisms of insulin action in normal and insulin-resistant states
7. Pharmacological strategies for reduction of lipid availability
8. Pharmacological approach in the treatment of insulin resistance
9. The effect of the new oral hypoglycemic agent A-4166 on glucose turnover in the high fat diet-induced and/or in the hereditary insulin resistance of rats
10. The role of troglitazone in treating the insulin resistance syndrome
11. Bimoclomol (BRLP-42) ameliorates peripheral neuropathy in streptozotocin-induced diabetic rats
12. Bimoclomol improves early electro-physiological signs of retinopathy in diabetic rats
13. The new Biorex compound increases insulin mediated glucose disposal in high fat diet-induced insulin resistance
14. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
15. A novel insulin sensitizer acts a co-ligand for peroxisome proliferator-activated receptor α and γ: Effect of PPARα activation on normal lipid metabolism in liver of Zucker fatty rats
16. Influence of dietary fat composition on development of insulin resistance in rats
17. In vivo insulin responsiveness for glucose uptake at eu- and hyperglycemic levels in diabetic rats
18. Dose response curve for in vivo insulin sensitivity in individual tissues in rats
19. Fish oil prevents insulin resistance induced by high fat feeding in rats
20. Mechanisms of liver and muscle insulin resistance induced by chronic high fat feeding
21. High fat diet-induced insulin resistance: Lessons and implications from animal studies
22. "Syndromes of insulin resistance" in the rat: Induction by diet and amelioration with benfluorex
23. A potent in vivo effect of ciglitazone on muscle insulin resistance induced by high fat feeding of rats
24. Triglycerides, acids, and insulin resistance-hyperinsulinemia
25. Skeletal muscle triglycerides: An aspect of regional adiposity and insulin resistance
26. Bimoclomol: A non-toxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects